| Literature DB >> 25886583 |
Claire Julian-Reynier1,2,3, Anne-Deborah Bouhnik4,5, D Gareth Evans6, Hilary Harris7, Christi J van Asperen8, Aad Tibben9, Joerg Schmidtke10, Irmgard Nippert11.
Abstract
BACKGROUND: No information is available on the attitudes of General Practitioners (GPs) and Breast Surgeons (BSs) to their delivery of genetic, environmental and lifestyle risk factor information about breast cancer. The aim of this study was to describe the Breast Cancer Risk Communication Behaviours (RCBs) reported by GPs and BSs in four European countries and to determine the relationships between their RCBs and their socio-occupational characteristics.Entities:
Mesh:
Year: 2015 PMID: 25886583 PMCID: PMC4393864 DOI: 10.1186/s12885-015-1281-2
Source DB: PubMed Journal: BMC Cancer ISSN: 1471-2407 Impact factor: 4.430
Figure 1Questions adressed to doctors on risk communication –InCRisC study.
Characteristics of the sample – InCRisC (N = 2094)
| France | Germany | The Netherlands | UK | Total | |
|---|---|---|---|---|---|
|
|
|
|
|
|
|
| Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | |
| Age* | 48.5 (9.2) | 54.2 (7.7) | 49.5 (8.0) | 45.1 (9.2) | 50.3 (9.0) |
| Number of years of medical practice* | 21.9 (9.1) | 25.0 (8.3) | 20.1 (8.7) | 16.5 (9.5) | 21.7 (9.3) |
| n (%) | n (%) | n (%) | n (%) | n (%) | |
| Gender male* | 170 (63.2) | 295 (65.7) | 175 (66.3) | 85 (41.1) | 725 (61.0) |
| Weekly number of consultations > 100* | 144 (53.5) | 411 (91.5) | 171 (64.8) | 131 (63.3) | 857 (72.1) |
|
|
|
|
|
|
|
| Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | |
| Age* | 52.1 (10.1) | 50.7 (7.4) | 46.7 (8.9) | 48.3 (8.7) | 50.0 (8.6) |
| Number of years of medical practice* | 25.8 (10.1) | 22.3 (7.9) | 16.3 (7.9) | 14.8 (8.9) | 20.8 (9.5) |
| n (%) | n (%) | n (%) | n (%) | n (%) | |
| Gender male* | 147 (87.5) | 250 (54.6) | 85 (69.7) | 105 (66.9) | 587 (64.9) |
| BCs newly diagnosed during the last year > 100* | 40 (16.6) | 105 (22.9) | 21 (17.2) | 75 (47.8) | 241 (26.6) |
BC: Breast Cancer.
*p < 0.001.
Risk factors presented to patients, depending on practitioners’ (GPs’ and Breast Surgeons’) speciality InCRisC (N=2094)
| GP (n=1189) | BS (n=905) | ||||
|---|---|---|---|---|---|
| Mean score ± SD | Rank | Mean score ± SD | Rank | p-value* | |
| Family history of BC | 3.4 ± 1.5 | 2 | 4.1 ± 1.2 | 1 | <.001 |
| HRT | 3.9 ± 1.1 | 1 | 3.8 ± 1.3 | 2 | 0.029 |
| Oral contraception | 3.2 ± 1.5 | 3 | 2.6 ± 1.7 | 8 | <.001 |
| Breast feeding | 2.8 ± 1.6 | 4 | 3.1 ± 1.5 | 5 | <.001 |
| Physical exercise | 2.6 ± 1.7 | 5 | 3.3 ± 1.7 | 3 | <.001 |
| Obesity | 2.5 ± 1.6 | 6 | 3.2 ± 1.6 | 4 | <.001 |
| Childbearing at a younger age | 2.2 ± 1.6 | 8 | 2.7 ± 1.6 | 7 | <.001 |
| Alcohol | 2.3 ± 1.7 | 7 | 2.8 ± 1.7 | 6 | <.001 |
| Risk factors for BC other than family history and HRT (sum) | 15.5 ± 7.8 | 17.7 ± 7.5 | <.001 | ||
BC: Breast Cancer/BS: Breast Surgeon/HRT: Hormonal Replacement Therapy.
*Adjusted for age, gender and country using multifactor ANOVAs.
Risk factors presented by the practitioners (GPs and Breast Surgeons), depending on the country of origin – InCRisC (N=2094)
| France (n=437) | Germany (n=907) | NTL (n=386) | UK (n=364) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Mean ± SD | Rank | Mean ± SD | Rank | Mean ± SD | Rank | Mean ± SD | Rank | p-value* | |
| Family history of BC | 3.8 ± 1.3 | 1 | 3.7 ± 1.5 | 2 | 3.5 ± 1.4 | 2 | 3.7 ± 1.4 | 2 | 0.023 |
| HRT | 3.8 ± 1.3 | 1 | 3.9 ± 1.2 | 1 | 3.7 ± 1.2 | 1 | 3.9 ± 1.0 | 1 | 0.002 |
| Oral contraception | 2.8 ± 1.7 | 3 | 2.8 ± 1.7 | 7 | 2.9 ± 1.5 | 3 | 3.3 ± 1.4 | 3 | <.001 |
| Breast feeding | 2.8 ± 1.7 | 3 | 3.3 ± 1.5 | 5 | 2.3 ± 1.5 | 4 | 2.9 ± 1.5 | 4 | <.001 |
| Obesity | 2.5 ± 1.7 | 5 | 3.4 ± 1.5 | 4 | 1.8 ± 1.5 | 5 | 2.8 ± 1.5 | 5 | <.001 |
| Physical exercise | 2.5 ± 1.8 | 5 | 3.8 ± 1.4 | 3 | 1.6 ± 1.5 | 7 | 2.3 ± 1.6 | 8 | <.001 |
| Child bearing at a younger age | 2.3 ± 1.7 | 7 | 2.8 ± 1.6 | 7 | 1.8 ± 1.5 | 5 | 2.5 ± 1.5 | 6 | <.001 |
| Alcohol | 2.2 ± 1.8 | 8 | 3.1 ± 1.6 | 6 | 1.6 ± 1.5 | 7 | 2.5 ± 1.6 | 6 | <.001 |
| Risk factors for BC other than family history and HRT (sum) | 15.0 ± 8.3 | 19.0 ± 8.1 | 12.0 ± 7.0 | 16.3 ± 7.4 | <.001 | ||||
BC: Breast Cancer/HRT: Hormonal Replacement Therapy.
*Adjusted for age, gender and specialty using multifactor ANOVAs.
Clusters based on the risk information presented to patients – InCRisC (N=2094)
| Formats used to communicate risk information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Numerical absolute risk n=1490 (71.2%) | Verbal formulation absolute risk n=893 (42.6%) | Numerical relative risk n=916 (43.7%) | Negative framing n=1398 (66.8%) | |||||
| n | (%) | n | (%) | n | (%) | n | (%) | |
|
| 368 | (100.0) | 0 | (0.0) | 0 | (0.0) | 368 | (100.0) |
|
| 479 | (66.8) | 249 | (34.7) | 280 | (39.1) | 21 | (2.9) |
|
| 267 | (100.0) | 0 | (0.0) | 267 | (100.0) | 267 | (100.0) |
|
| 376 | (100.0) | 376 | (100.0) | 157 | (41.8) | 376 | (100.0) |
|
| 0 | (0.0) | 268 | (73.2) | 212 | (57.9) | 366 | (100.0) |
| GPs (n=1189) | 830 | (69.8) | 475 | (39.9) | 463 | (38.9) | 743 | (62.5) |
| BS (n=905) | 660 | (72.9) | 418 | (46.2) | 453 | (50.0) | 655 | (72.4) |
Description of clusters in terms of physicians’ characteristics – InCRisC (N=2094)
| Cluster 1, n=368 (17.6%) | Cluster 2, n=717 (34.2%) | Cluster 3, n=267 (12.7%) | Cluster 4, n=376 (18.0%) | Cluster 5, n=366 (17.5%) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean (SD) | AOR [CI 95%] | p | Mean (SD) | AOR [CI 95%] | p | Mean (SD) | AOR [CI 95%] | p | Mean (SD) | AOR | Mean (SD) | AOR [CI 95%] | p | |
| Age | 48.9 (9.1) | 0.97 [0.96;0.99] | 0.006 | 50.3 (8.9) | 0.99 [0.98;1.01] | 0.377 | 48.9 (8.4) | 0.97 [0.96;0.99] | 0.011 | 50.9 (8.7) | 1 | 51.2 (8.5) | 0.99 [0.98;1.01] | 0.585 |
| n (%) | n (%) | n (%) | n (%) | n (%) | ||||||||||
| Gender | ||||||||||||||
| Female | 156 (19.9) | 1 | 258 (33.0) | 1 | 88 (11.3) | 1 | 133 (17.0) | 1 | 147 (18.8) | 1 | ||||
| Male | 212 (16.2) | 0.91 [0.66;1.25] | 0.564 | 459 (35.0) | 0.98 [0.74;1.30] | 0.886 | 179 (13.6) | 1.18 [0.82;1.69] | 0.374 | 243 (18.5) | 1 | 219 (16.7) | 0.81 [0.59;1.12] | 0.207 |
| Country | ||||||||||||||
| France | 62 (14.2) | 1 | 186 (42.6) | 1 | 71 (16.2) | 1 | 55 (12.6) | 1 | 63 (14.4) | 1 | ||||
| Germany | 165 (18.2) | 0.95 [0.62;1.46] | 0.817 | 266 (29.3) | 0.49 [0.34;0.70] | <.001 | 81 (8.9) | 0.38 [0.24;0.59] | <.001 | 174 (19.2) | 1 | 221 (23.4) | 1.14 [0.75;1.73] | 0.551 |
| NL | 48 (12.4) | 0.53 [0.31;0.89] | 0.016 | 144 (37.3) | 0.54 [0.35;0.81] | 0.003 | 63 (16.3) | 0.65 [0.40;1.05] | 0.081 | 74 (19.2) | 1 | 57 (14.8) | 0.63 [0.38;1.05] | 0.076 |
| UK | 93 (25.5) | 1.04 [0.64;1.70] | 0.859 | 121 (33.2) | 0.49 [0.32;0.75] | 0.001 | 52 (14.3) | 0.52 [0.31;0.86] | 0.011 | 73 (20.1) | 1 | 25 (6.9) | 0.29 [0.16;0.51] | <.001 |
| Speciality | ||||||||||||||
| BS | 144 (15.9) | 1 | 258 (28.5) | 1 | 147 (16.2) | 1 | 195 (21.5) | 1 | 161 (17.8) | 1 | ||||
| GPs | 224 (18.8) | 1.76 [1.31;2.38] | <.001 | 459 (38.6) | 1.86 [1.44;2.41] | <.001 | 120 (10.1) | 0.82 [0.59;1.13] | 0.225 | 181 (15.2) | 1 | 205 (17.2) | 1.47 [1.09;1.98] | 0.011 |
Cluster 1: “No Verbal formulation & no Relative Risk mentioned” (n=368).
Cluster 2: “No negative framing” (n=717).
Cluster 3: “No Verbal Formulation” (n=267).
Cluster 4: “Risks presented in all 4 ways” (n=376).
Cluster 5: “Absolute numerical risks not presented” (n=366).